title: [Neuroleptic malignant syndrome associated with olanzapine].
authors.forename: M M
authors.initials: MM
authors.lastname: García López
authors.forename: L
authors.initials: L
authors.lastname: Ciprés
authors.forename: E
authors.initials: E
authors.lastname: de Cendra
authors.forename: J
authors.initials: J
authors.lastname: Vilalta Franch
mesh_terms: D014150:Antipsychotic Agents / Q000009:adverse effects*; D001569:Benzodiazepines; D006801:Humans; D008297:Male; D008875:Middle Aged; D009459:Neuroleptic Malignant Syndrome / Q000209:etiology*; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects / Q000031:analogs & derivatives*; D012563:Schizophrenia, Paranoid / Q000150:complications / Q000188:drug therapy; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects*
chemical_list: D014150:Antipsychotic Agents; D001569:Benzodiazepines; D000077152:Olanzapine; D010890:Pirenzepine; D017367:Selective Serotonin Reuptake Inhibitors